Sign in
4

Changes in Ownership

RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001104659-23-117365

EVP, Head of North America sold 9,150 shares at an average $28.45 ($260,287)

  • EVP, Head of North America acquired 9,150 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Lee Jennifer Kayden · EVP, Head of North America

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2023-11-08 Exercise or conversion : show line 1 in the form 10b5-1 +5,712 $6.80 $38,842 7,359 D
2023-11-08 Sale : show line 2 in the form 10b5-1 −3,479 $28.64 $99,649 3,880 D
2023-11-08 Sale : show line 3 in the form 10b5-1 −2,233 $29.31 $65,456 1,647 D
2023-11-09 Exercise or conversion : show line 4 in the form 10b5-1 +3,438 $6.80 $23,378 5,085 D
2023-11-09 Sale : show line 5 in the form 10b5-1 −1,719 $27.37 $47,051 3,366 D
2023-11-09 Sale : show line 6 in the form 10b5-1 −1,719 $28.00 $48,132 1,647 D
Open-market sales · 9,150 sh · avg $28.45 · $260,287

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2023-11-08 Exercise or conversion : show line 7 in the form 10b5-1 Stock Option (Right to Buy) −5,712 61,880 D
2023-11-09 Exercise or conversion : show line 8 in the form 10b5-1 Stock Option (Right to Buy) −3,438 58,442 D
Loading xslF345X05/tm2330582-1_4seq1.xml…